technetium tc 99m hydroxymethylene diphosphonate has been researched along with furosemide in 1 studies
| Studies (technetium tc 99m hydroxymethylene diphosphonate) | Trials (technetium tc 99m hydroxymethylene diphosphonate) | Recent Studies (post-2010) (technetium tc 99m hydroxymethylene diphosphonate) | Studies (furosemide) | Trials (furosemide) | Recent Studies (post-2010) (furosemide) |
|---|---|---|---|---|---|
| 618 | 35 | 87 | 13,631 | 1,358 | 2,486 |
| Protein | Taxonomy | technetium tc 99m hydroxymethylene diphosphonate (IC50) | furosemide (IC50) |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 3.76 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 3.76 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedont, R; Raabe, R; Taylor, A | 1 |
1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and furosemide
| Article | Year |
|---|---|
Prolonged half-life following diuretic radionuclide urography as evidence of ureteral obstruction.
Topics: Aged; Furosemide; Half-Life; Humans; Kidney Pelvis; Male; Prostatic Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate; Ureteral Obstruction; Urinary Bladder Neoplasms | 1985 |